VALCREST PHARMACEUTICALS Trademark

Trademark Overview

On Monday, March 2, 2020, a trademark application was filed for VALCREST PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the VALCREST PHARMACEUTICALS trademark a serial number of 88817267. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2023. This trademark is owned by Valcrest Pharmaceuticals, LLC. The VALCREST PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, except for antiviral pharmaceutical compounds and substances, used to treat infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive disorders and respiratory conditions
valcrest pharmaceuticals

General Information

Serial Number88817267
Word MarkVALCREST PHARMACEUTICALS
Filing DateMonday, March 2, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 16, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations, except for antiviral pharmaceutical compounds and substances, used to treat infectious diseases, cancer, pain, inflammation, cardiovascular diseases, neurological diseases, dermatological diseases, gastrointestinal diseases, musculoskeletal diseases, endocrine and metabolic diseases, ophthalmologic diseases, reproductive disorders and respiratory conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, March 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameValcrest Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNaples, FL 34108
Party NameValcrest Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNaples, FL 34108

Trademark Events

Event DateEvent Description
Monday, May 15, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 15, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 16, 2022SOU EXTENSION 3 GRANTED
Friday, September 16, 2022SOU EXTENSION 3 FILED
Friday, September 16, 2022TEAS EXTENSION RECEIVED
Wednesday, March 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 14, 2022SOU EXTENSION 2 GRANTED
Monday, March 14, 2022SOU EXTENSION 2 FILED
Monday, March 14, 2022TEAS EXTENSION RECEIVED
Thursday, September 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 1 GRANTED
Tuesday, September 14, 2021SOU EXTENSION 1 FILED
Tuesday, September 14, 2021TEAS EXTENSION RECEIVED
Tuesday, April 13, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 27, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 8, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 6, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION E-MAILED
Wednesday, May 20, 2020NON-FINAL ACTION WRITTEN
Wednesday, May 20, 2020ASSIGNED TO EXAMINER
Sunday, March 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 5, 2020NEW APPLICATION ENTERED

Related Keywords

pharmaceuticals valcrest diseases pharmaceutical musculoskeletal dermatological endocrine gastrointestinal metabolic respiratory conditions disorders